Tekla Life Sciences Stock Today
| HQL Stock | USD 12.99 0.19 1.48% |
Performance0 of 100
| Odds Of DistressOver 55
|
Tekla Life is selling for 12.99 as of the 23rd of April 2024. This is a 1.48 percent increase since the beginning of the trading day. The stock's lowest day price was 12.85. Tekla Life has over 55 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for Tekla Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Financial Services | IPO Date 4th of May 1992 | Classification Financials |
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Asset Management classification in the United States and is traded on New York Stock Exchange.. The company has 26.79 M outstanding shares of which 21.32 K shares are currently shorted by investors with about 0.34 days to cover. More on Tekla Life Sciences
Moving together with Tekla Stock
| 0.63 | ECPG | Encore Capital Group Financial Report 1st of May 2024 | PairCorr |
Moving against Tekla Stock
| 0.67 | FCFS | FirstCash Earnings Call This Week | PairCorr |
| 0.44 | WRLD | World Acceptance Report 2nd of May 2024 | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Tekla Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Tekla Life's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Tekla Life or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Tekla Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Tekla Life's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| Chairman | Oleg Pohotsky | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Asset Management & Custody Banks, Financial Services, Financials, Capital Markets, Asset Management, Financial Services (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Tekla Life report their recommendations after researching Tekla Life's financial statements, talking to executives and customers, or listening in on Tekla Life's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Tekla Life Sciences. The Tekla consensus assessment is calculated by taking the average forecast from all of the analysts covering Tekla Life. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Tekla Life's historical financial statements, Tekla Life Sciences may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Tekla Life Sciences is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Tekla Life Sciences (HQL) is traded on New York Stock Exchange in USA. It is located in 1900 Market Street, Philadelphia, PA, United States, 19103 and employs 13 people. Tekla Life is listed under Asset Management & Custody Banks category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 342.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tekla Life's market, we take the total number of its shares issued and multiply it by Tekla Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Tekla Life Sciences runs under Capital Markets sector within Financials industry. The entity has 26.79 M outstanding shares of which 21.32 K shares are currently shorted by investors with about 0.34 days to cover.
Tekla Life Sciences has about 292.4 K in cash with (12.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Tekla Life Probability Of Bankruptcy
Ownership AllocationTekla Life Sciences shows a total of 26.79 Million outstanding shares. 30% of Tekla Life Sciences outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Tekla Ownership Details
Tekla Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Tekla Life jumping above the current price in 90 days from now is roughly 96.0%. The Tekla Life Sciences probability density function shows the probability of Tekla Life stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Tekla Life has a beta of 0.7442. This usually indicates as returns on the market go up, Tekla Life average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Tekla Life Sciences will be expected to be much smaller as well. Additionally, tekla Life Sciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Tekla Life to move above the current price in 90 days from now is roughly 96.0 (This Tekla Life Sciences probability density function shows the probability of Tekla Stock to fall within a particular range of prices over 90 days) .
Tekla Life Historical Income Statement
Tekla Life Sciences Income Statement is one of the three primary financial statements used for reporting Tekla's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Tekla Life Sciences revenue and expense. Tekla Life Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Tekla Life's Total Revenue is quite stable compared to the past year. Gross Profit is expected to rise to about 28.4 M this year, although the value of Other Operating Expenses will most likely fall to about 1 M. View More FundamentalsTekla Stock Against Markets
Picking the right benchmark for Tekla Life stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Tekla Life stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Tekla Life is critical whether you are bullish or bearish towards Tekla Life Sciences at a given time. Please also check how Tekla Life's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Tekla Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Tekla Life Corporate Management
Elected by the shareholders, the Tekla Life's board of directors comprises two types of representatives: Tekla Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tekla. The board's role is to monitor Tekla Life's management team and ensure that shareholders' interests are well served. Tekla Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tekla Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Bonney | Independent Trustee | Profile | |
| Lucinda Stebbins | Independent Trustee | Profile | |
| Jeffrey Bailey | Independent Trustee | Profile | |
| Rakesh Jain | Independent Trustee | Profile |
How to buy Tekla Stock?
Before investing in Tekla Life, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Tekla Life. To buy Tekla Life stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Tekla Life. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Tekla Life stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Tekla Life Sciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Tekla Life Sciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Tekla Life Sciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Tekla Stock please use our How to Invest in Tekla Life guide.
Already Invested in Tekla Life Sciences?
The danger of trading Tekla Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Tekla Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Tekla Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Tekla Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Tekla Stock analysis
When running Tekla Life's price analysis, check to measure Tekla Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Life is operating at the current time. Most of Tekla Life's value examination focuses on studying past and present price action to predict the probability of Tekla Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Life's price. Additionally, you may evaluate how the addition of Tekla Life to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Tekla Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Dividend Share 1.3 | Earnings Share 0.79 | Revenue Per Share 0.134 | Quarterly Revenue Growth 0.344 |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.